Completed

Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia: Single-Blind Clinical Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Respiratory Pediatric Physiotherapy

+ Control Group

Other
Who is being recruted

Infections+2

+ Lung Diseases

+ Pneumonia

From 1 to 7 Years
+17 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-Controlled
Interventional
Study Start: February 2018
See protocol details

Summary

Principal SponsorHospital Infantil de Mexico Federico Gomez
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 3, 2018

Actual date on which the first participant was enrolled.

This study focuses on evaluating the effectiveness of a treatment called Respiratory Pediatric Physiotherapy (RPP) for children who are hospitalized with pneumonia. Researchers aim to determine if RPP, when used alongside traditional methods like postural drainage and muscle compression, can help reduce the severity of pneumonia symptoms and shorten the length of hospital stays. The goal is to see if this combined approach can decrease the severity score by 1.5 points and reduce hospitalization by two days, potentially offering a more efficient treatment to improve recovery in young patients. Participants in this study will receive either the RPP treatment or the traditional methods of postural drainage and muscle compression. The results will be measured by observing changes in the clinical severity of pneumonia using a special scoring system known as the Wang score. By comparing these scores, researchers hope to identify the effectiveness of RPP and its impact on recovery times. The study is designed to provide reliable results with a high level of confidence, helping to determine if RPP should be more widely used in treating pneumonia in children.

Official TitleClinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia: Single-Blind Clinical Trial
NCT06174454
Principal SponsorHospital Infantil de Mexico Federico Gomez
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

88 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 1 to 7 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

InfectionsLung DiseasesPneumoniaRespiratory Tract DiseasesRespiratory Tract Infections

Criteria

5 inclusion criteria required to participate
Patients from the Hospital Infantil de México Federico Góme with diagnosis of pneumonia (considering the diagnostic criteria of the WHO and the Guidelines for Nosocomial Pneumonia from the infectiology department.

Patients aged 0 to 8 years old.

A minimum HS of 72 hours.

Having informed consent.

Show More Criteria

12 exclusion criteria prevent from participating
Presenting a fever state for more than three days. Performing physiotherapy increases the body's peripheral temperature.

Presenting an oxygen saturation below 80%.

Requiring mechanical ventilation.

Hemodynamic instability.

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
The intervention group will be subject to RPP. Techniques of slow expiration will be used and slow inspiration for the sweeping of secretions, during its expulsion forced expiratory techniques will be used (tracheal reflex). 10 sessions will be performed, one a day from Monday to Friday, with a duration of 10 to 15 minutes.

Group II

Placebo
Will be subject to PD plus muscle belly compressions of the upper limbs for 10 sessions, one session a day from Monday to Friday, with a duration de 10 to 15 minutes per patient. Both groups will receive the usual treatment for pneumonia prescribed by their treating doctor.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Hospital Infantil de México Federico Gómez

Mexico City, MexicoOpen Hospital Infantil de México Federico Gómez in Google Maps
CompletedOne Study Center